RAICHUR, Indien, 13. März 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), ein führender Hersteller von Wirkstoffen und Formulierungen, gibt bekannt, dass der Sachverständigenausschuss (SEC) der CDSCO sein neues Prüfpräparat (Investigational New Drug, IND) […]
POMONA, Calif., March 12, 2025 /PRNewswire/ — Cal Poly Pomona’s Singelyn Graduate School of Business (CPP SGSB) and the College of Pharmacy (COP) at Western University of Health Sciences (WesternU) are proud to announce an […]
Huawei Unveils Digital Training 2.0 Solution at MWC 2025 BARCELONA, Spain, March 13, 2025 /PRNewswire/ — Huawei introduced its Digital Training 2.0 solution at this year’s MWC forum on "Nurturing ICT Talents to Enhance Intelligence […]
Huawei Introduces Digital Training 2.0 Solution at MWC Forum in Barcelona Huawei unveiled its Digital Training 2.0 solution at the forum “Cultivating ICT Talent to Amplify Digital Education” during this year’s MWC in Barcelona, Spain […]
YONGIN, South Korea, March 12, 2025 /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 […]
